This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Universitè Catholique De Louvain. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2019
Title: Stéphane Eeckhoudt: Innovator in Cell Transplantation
Introduction
Stéphane Eeckhoudt is a notable inventor based in Erbisoeul, Belgium. He has made significant contributions to the field of cell transplantation, holding a total of 3 patents. His work focuses on innovative compositions and methods that enhance the efficacy of cell transplantation procedures.
Latest Patents
Stéphane's latest patents include groundbreaking inventions related to cell transplantation. One of his notable patents is titled "Compositions and methods for cell transplantation," which provides a composition containing procoagulant cells along with at least one factor Xa inhibitor, preferably rivaroxaban, and at least one thrombin inhibitor, preferably bivalirudin. Another patent under the same title also focuses on compositions for cell transplantation, offering a composition that includes procoagulant cells and at least one antithrombin activator, preferably unfractionated heparin, along with at least one thrombin inhibitor, preferably bivalirudin. These inventions aim to improve the outcomes of cell transplantation procedures.
Career Highlights
Stéphane has worked with prestigious institutions such as Université Catholique De Louvain. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of cell transplantation.
Collaborations
Throughout his career, Stéphane has collaborated with notable individuals, including Xavier Stephenne and Etienne Sokal. These collaborations have contributed to the advancement of his research and inventions.
Conclusion
Stéphane Eeckhoudt is a prominent inventor whose work in cell transplantation has led to significant advancements in the field. His innovative patents and collaborations reflect his commitment to improving medical procedures and patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
